Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49


MUC16 suppresses human and murine innate immune responses.

Felder M, Kapur A, Rakhmilevich AL, Qu X, Sondel PM, Gillies SD, Connor J, Patankar MS.

Gynecol Oncol. 2019 Jan 6. pii: S0090-8258(18)31537-3. doi: 10.1016/j.ygyno.2018.12.023. [Epub ahead of print]


Oxidative Phosphorylation: A Target for Novel Therapeutic Strategies Against Ovarian Cancer.

Nayak AP, Kapur A, Barroilhet L, Patankar MS.

Cancers (Basel). 2018 Sep 18;10(9). pii: E337. doi: 10.3390/cancers10090337. Review.


Polarization-resolved second harmonic generation imaging of human ovarian cancer.

Campbell KR, Chaudhary R, Handel JM, Patankar MS, Campagnola PJ.

J Biomed Opt. 2018 Jun;23(6):1-8. doi: 10.1117/1.JBO.23.6.066501.


Alternatively-Activated Macrophages Upregulate Mesothelial Expression of P-Selectin to Enhance Adhesion of Ovarian Cancer Cells.

Carroll MJ, Fogg KC, Patel HA, Krause HB, Mancha AS, Patankar MS, Weisman PS, Barroilhet L, Kreeger PK.

Cancer Res. 2018 Jul 1;78(13):3560-3573. doi: 10.1158/0008-5472.CAN-17-3341. Epub 2018 May 8.


Oxidative stress via inhibition of the mitochondrial electron transport and Nrf-2-mediated anti-oxidative response regulate the cytotoxic activity of plumbagin.

Kapur A, Beres T, Rathi K, Nayak AP, Czarnecki A, Felder M, Gillette A, Ericksen SS, Sampene E, Skala MC, Barroilhet L, Patankar MS.

Sci Rep. 2018 Jan 18;8(1):1073. doi: 10.1038/s41598-018-19261-w.


Trans10,cis12 conjugated linoleic acid inhibits proliferation and migration of ovarian cancer cells by inducing ER stress, autophagy, and modulation of Src.

Shahzad MMK, Felder M, Ludwig K, Van Galder HR, Anderson ML, Kim J, Cook ME, Kapur AK, Patankar MS.

PLoS One. 2018 Jan 11;13(1):e0189524. doi: 10.1371/journal.pone.0189524. eCollection 2018.


M2 macrophages induce ovarian cancer cell proliferation via a heparin binding epidermal growth factor/matrix metalloproteinase 9 intercellular feedback loop.

Carroll MJ, Kapur A, Felder M, Patankar MS, Kreeger PK.

Oncotarget. 2016 Dec 27;7(52):86608-86620. doi: 10.18632/oncotarget.13474.


Modulation of oxidative stress and subsequent induction of apoptosis and endoplasmic reticulum stress allows citral to decrease cancer cell proliferation.

Kapur A, Felder M, Fass L, Kaur J, Czarnecki A, Rathi K, Zeng S, Osowski KK, Howell C, Xiong MP, Whelan RJ, Patankar MS.

Sci Rep. 2016 Jun 8;6:27530. doi: 10.1038/srep27530.


Formulation, Characterization, and Antitumor Properties of Trans- and Cis-Citral in the 4T1 Breast Cancer Xenograft Mouse Model.

Zeng S, Kapur A, Patankar MS, Xiong MP.

Pharm Res. 2015 Aug;32(8):2548-58. doi: 10.1007/s11095-015-1643-0. Epub 2015 Feb 12.


MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress.

Felder M, Kapur A, Gonzalez-Bosquet J, Horibata S, Heintz J, Albrecht R, Fass L, Kaur J, Hu K, Shojaei H, Whelan RJ, Patankar MS.

Mol Cancer. 2014 May 29;13:129. doi: 10.1186/1476-4598-13-129. Review.


An endogenous aryl hydrocarbon receptor ligand inhibits proliferation and migration of human ovarian cancer cells.

Wang K, Li Y, Jiang YZ, Dai CF, Patankar MS, Song JS, Zheng J.

Cancer Lett. 2013 Oct 28;340(1):63-71. doi: 10.1016/j.canlet.2013.06.026. Epub 2013 Jul 9.


Differential expression of proteins in naïve and IL-2 stimulated primary human NK cells identified by global proteomic analysis.

Ma D, Cao W, Kapur A, Felder M, Scarlett CO, Patankar MS, Li L.

J Proteomics. 2013 Oct 8;91:151-163. doi: 10.1016/j.jprot.2013.06.024. Epub 2013 Jun 25.


Estradiol 17β and its metabolites stimulate cell proliferation and antagonize ascorbic acid-suppressed cell proliferation in human ovarian cancer cells.

Li HH, Zhao YJ, Li Y, Dai CF, Jobe SO, Yang XS, Li XF, Patankar MS, Magness RR, Zheng J.

Reprod Sci. 2014 Jan;21(1):102-11. doi: 10.1177/1933719113492211. Epub 2013 Jun 11.


Terpenoids from Zingiber officinale (Ginger) induce apoptosis in endometrial cancer cells through the activation of p53.

Liu Y, Whelan RJ, Pattnaik BR, Ludwig K, Subudhi E, Rowland H, Claussen N, Zucker N, Uppal S, Kushner DM, Felder M, Patankar MS, Kapur A.

PLoS One. 2012;7(12):e53178. doi: 10.1371/journal.pone.0053178. Epub 2012 Dec 31.


Endothelial caveolar hub regulation of adenosine triphosphate-induced endothelial nitric oxide synthase subcellular partitioning and domain-specific phosphorylation.

Ramadoss J, Liao WX, Morschauser TJ, Lopez GE, Patankar MS, Chen DB, Magness RR.

Hypertension. 2012 May;59(5):1052-9. doi: 10.1161/HYPERTENSIONAHA.111.189498. Epub 2012 Mar 26.


The mucin MUC16 (CA125) binds to NK cells and monocytes from peripheral blood of women with healthy pregnancy and preeclampsia.

Tyler C, Kapur A, Felder M, Belisle JA, Trautman C, Gubbels JA, Connor JP, Patankar MS.

Am J Reprod Immunol. 2012 Jul;68(1):28-37. doi: 10.1111/j.1600-0897.2012.01113.x. Epub 2012 Mar 1.


The immunomodulating roles of glycoproteins in epithelial ovarian cancer.

Patankar MS, Gubbels JA, Felder M, Connor JP.

Front Biosci (Elite Ed). 2012 Jan 1;4:631-50. Review.


RT-SVR+q: a strategy for post-Mascot analysis using retention time and q value metric to improve peptide and protein identifications.

Cao W, Ma D, Kapur A, Patankar MS, Ma Y, Li L.

J Proteomics. 2011 Dec 21;75(2):480-90. doi: 10.1016/j.jprot.2011.08.013. Epub 2011 Aug 24.


Ab-IL2 fusion proteins mediate NK cell immune synapse formation by polarizing CD25 to the target cell-effector cell interface.

Gubbels JA, Gadbaw B, Buhtoiarov IN, Horibata S, Kapur AK, Patel D, Hank JA, Gillies SD, Sondel PM, Patankar MS, Connor J.

Cancer Immunol Immunother. 2011 Dec;60(12):1789-800. doi: 10.1007/s00262-011-1072-9. Epub 2011 Jul 27.


HN125: A Novel Immunoadhesin Targeting MUC16 with Potential for Cancer Therapy.

Xiang X, Feng M, Felder M, Connor JP, Man YG, Patankar MS, Ho M.

J Cancer. 2011;2:280-91. Epub 2011 May 16.


Expression and roles of Slit/Robo in human ovarian cancer.

Dai CF, Jiang YZ, Li Y, Wang K, Liu PS, Patankar MS, Zheng J.

Histochem Cell Biol. 2011 May;135(5):475-85. doi: 10.1007/s00418-011-0806-2. Epub 2011 Apr 5.


Differential internalization of hu14.18-IL2 immunocytokine by NK and tumor cell: impact on conjugation, cytotoxicity, and targeting.

Buhtoiarov IN, Neal ZC, Gan J, Buhtoiarova TN, Patankar MS, Gubbels JA, Hank JA, Yamane B, Rakhmilevich AL, Reisfeld RA, Gillies SD, Sondel PM.

J Leukoc Biol. 2011 Apr;89(4):625-38. doi: 10.1189/jlb.0710422. Epub 2011 Jan 19.


Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes.

Belisle JA, Horibata S, Jennifer GA, Petrie S, Kapur A, André S, Gabius HJ, Rancourt C, Connor J, Paulson JC, Patankar MS.

Mol Cancer. 2010 May 24;9:118. doi: 10.1186/1476-4598-9-118.


The detection, treatment, and biology of epithelial ovarian cancer.

Gubbels JA, Claussen N, Kapur AK, Connor JP, Patankar MS.

J Ovarian Res. 2010 Mar 29;3:8. doi: 10.1186/1757-2215-3-8.


MUC16 provides immune protection by inhibiting synapse formation between NK and ovarian tumor cells.

Gubbels JA, Felder M, Horibata S, Belisle JA, Kapur A, Holden H, Petrie S, Migneault M, Rancourt C, Connor JP, Patankar MS.

Mol Cancer. 2010 Jan 20;9:11. doi: 10.1186/1476-4598-9-11.


Early prenatal androgenization results in diminished ovarian reserve in adult female rhesus monkeys.

Dumesic DA, Patankar MS, Barnett DK, Lesnick TG, Hutcherson BA, Abbott DH.

Hum Reprod. 2009 Dec;24(12):3188-95. doi: 10.1093/humrep/dep324. Epub 2009 Sep 9.


Characterization of the tumor marker muc16 (ca125) expressed by murine ovarian tumor cell lines and identification of a panel of cross-reactive monoclonal antibodies.

Goodell CA, Belisle JA, Gubbels JA, Migneault M, Rancourt C, Connor J, Kunnimalaiyaan M, Kravitz R, Tucker W, Zwick M, Patankar MS.

J Ovarian Res. 2009 Jun 18;2(1):8. doi: 10.1186/1757-2215-2-8.


Mesothelin, Stereocilin, and Otoancorin are predicted to have superhelical structures with ARM-type repeats.

Sathyanarayana BK, Hahn Y, Patankar MS, Pastan I, Lee B.

BMC Struct Biol. 2009 Jan 7;9:1. doi: 10.1186/1472-6807-9-1.


Peritoneal natural killer cells from epithelial ovarian cancer patients show an altered phenotype and bind to the tumour marker MUC16 (CA125).

Belisle JA, Gubbels JA, Raphael CA, Migneault M, Rancourt C, Connor JP, Patankar MS.

Immunology. 2007 Nov;122(3):418-29. Epub 2007 Jul 6.


Analysis of protein-linked glycosylation in a sperm-somatic cell adhesion system.

Sutton-Smith M, Wong NK, Khoo KH, Wu SW, Yu SY, Patankar MS, Easton R, Lattanzio FA, Morris HR, Dell A, Clark GF.

Glycobiology. 2007 Jun;17(6):553-67. Epub 2007 Mar 2.


Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors.

Gubbels JA, Belisle J, Onda M, Rancourt C, Migneault M, Ho M, Bera TK, Connor J, Sathyanarayana BK, Lee B, Pastan I, Patankar MS.

Mol Cancer. 2006 Oct 26;5(1):50.


Differential O-glycosylation of a conserved domain expressed in murine and human ZP3.

Chalabi S, Panico M, Sutton-Smith M, Haslam SM, Patankar MS, Lattanzio FA, Morris HR, Clark GF, Dell A.

Biochemistry. 2006 Jan 17;45(2):637-47.


Potent suppression of natural killer cell response mediated by the ovarian tumor marker CA125.

Patankar MS, Jing Y, Morrison JC, Belisle JA, Lattanzio FA, Deng Y, Wong NK, Morris HR, Dell A, Clark GF.

Gynecol Oncol. 2005 Dec;99(3):704-13. Epub 2005 Aug 29.


Murine and human zona pellucida 3 derived from mouse eggs express identical O-glycans.

Dell A, Chalabi S, Easton RL, Haslam SM, Sutton-Smith M, Patankar MS, Lattanzio F, Panico M, Morris HR, Clark GF.

Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15631-6. Epub 2003 Dec 12.


Characterization of the oligosaccharides associated with the human ovarian tumor marker CA125.

Kui Wong N, Easton RL, Panico M, Sutton-Smith M, Morrison JC, Lattanzio FA, Morris HR, Clark GF, Dell A, Patankar MS.

J Biol Chem. 2003 Aug 1;278(31):28619-34. Epub 2003 May 6.


The expression of free oligosaccharides in human seminal plasma.

Chalabi S, Easton RL, Patankar MS, Lattanzio FA, Morrison JC, Panico M, Morris HR, Dell A, Clark GF.

J Biol Chem. 2002 Sep 6;277(36):32562-70. Epub 2002 Jun 12.


The species recognition system: a new corollary for the human fetoembryonic defense system hypothesis.

Clark GF, Dell A, Morris HR, Patankar MS, Easton RL.

Cells Tissues Organs. 2001;168(1-2):113-21. Review.


Structural analysis of murine zona pellucida glycans. Evidence for the expression of core 2-type O-glycans and the Sd(a) antigen.

Easton RL, Patankar MS, Lattanzio FA, Leaven TH, Morris HR, Clark GF, Dell A.

J Biol Chem. 2000 Mar 17;275(11):7731-42.


Direct evidence for the involvement of carbohydrate sequences in human sperm-zona pellucida binding.

Ozgur K, Patankar MS, Oehninger S, Clark GF.

Mol Hum Reprod. 1998 Apr;4(4):318-24.


Opinion: Hu-FEDS: in search of 'universal self'.

Clark GF, Patankar MS.

Mol Hum Reprod. 1997 Nov;3(11):985-7. Review. No abstract available.


Expression of glycans linked to natural killer cell inhibition on the human zona pellucida.

Patankar MS, Ozgur K, Oehninger S, Dell A, Morris H, Seppala M, Clark GF.

Mol Hum Reprod. 1997 Jun;3(6):501-5.


The malaria circumsporozoite protein: interaction of the conserved regions I and II-plus with heparin-like oligosaccharides in heparan sulfate.

Ying P, Shakibaei M, Patankar MS, Clavijo P, Beavis RC, Clark GF, Frevert U.

Exp Parasitol. 1997 Feb;85(2):168-82.


Gender-specific glycosylation of human glycodelin affects its contraceptive activity.

Morris HR, Dell A, Easton RL, Panico M, Koistinen H, Koistinen R, Oehninger S, Patankar MS, Seppala M, Clark GF.

J Biol Chem. 1996 Dec 13;271(50):32159-67.


Glycodelin from seminal plasma is a differentially glycosylated form of contraceptive glycodelin-A.

Koistinen H, Koistinen R, Dell A, Morris HR, Easton RL, Patankar MS, Oehninger S, Clark GF, Seppälä M.

Mol Hum Reprod. 1996 Oct;2(10):759-65.


A role for glycoconjugates in human development: the human feto-embryonic defence system hypothesis.

Clark GF, Oehninger S, Patankar MS, Koistinen R, Dell A, Morris HR, Koistinen H, Seppälä M.

Hum Reprod. 1996 Mar;11(3):467-73. Review.


New concepts in human sperm-zona pellucida interaction.

Clark GF, Patankar MS, Hinsch KD, Oehninger S.

Hum Reprod. 1995 Oct;10 Suppl 1:31-7. Review.


A revised structure for fucoidan may explain some of its biological activities.

Patankar MS, Oehninger S, Barnett T, Williams RL, Clark GF.

J Biol Chem. 1993 Oct 15;268(29):21770-6.

Supplemental Content

Loading ...
Support Center